Training activity information

Details

Analyse and interpret results from electrophoresis investigations including:

  • HPLC
  • Gel electrophoresis

Type

Developmental training activity (DTA)

Evidence requirements

Evidence the activity has been undertaken by the trainee​.

Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.

An action plan to implement learning and/or to address skills or knowledge gaps identified.

Reflective practice guidance

The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.

Before action

What are the intended outcomes of the training activity?

  • How will reviewing the specified learning outcomes help you focus on the requirement to analyse and interpret results generated by HPLC and gel electrophoresis?
  • In what ways will this activity develop your ability to select the most appropriate techniques for investigating clinical presentations such as red and white cell disorders or haematological malignancies?
  • How will you ensure you can clearly describe the limitations of these electrophoresis techniques when applied to clinical investigations in haematology?
  • What steps will you take to apply the principles of internal quality control (IQC) and external quality assessment (EQA) to draw valid conclusions about the performance of these assays?
  • How will this training activity prepare you to demonstrate appropriate communication skills when presenting your findings and case interpretations to healthcare professional colleagues?
  • How will you gain the detailed practical knowledge and understanding required to generate a differential diagnosis based on these results?

What do you anticipate you will learn from the experience?

  • What do you expect to learn about correlating complex patterns from HPLC plots and gel electrophoresis with specific clinical disorders like thalassaemias or haemoglobinopathies?
  • How do you anticipate this experience will improve your ability to identify necessary downstream or reflex tests to aid in disease classification?
  • What insights do you hope to gain regarding the advantages and disadvantages of using HPLC versus gel electrophoresis in various diagnostic scenarios?
  • How will you use this activity to learn how IQC and EQA data are used to determine if a run is valid or if the results require technical troubleshooting?
  • In what ways do you anticipate this experience will prepare you for the interpretive and analytical responsibilities required for post-programme professional practice?

What actions will you take in preparation for the experience?

  • How will you discuss the requirements of this activity with your training officer to ensure you understand the laboratory’s protocols and the expected standards for result interpretation?
  • Which theoretical principles of protein migration, HPLC elution times, and gel banding patterns will you review to support your analytical accuracy?
  • How can you use the laboratory’s SOPs and quality control records to familiarise yourself with the appearance of valid runs versus performance failures before you begin?
  • What case studies or reference libraries of known haemoglobin variants will you study to prepare for the challenge of interpreting complex or rare electrophoretic patterns?
  • How will you prepare for potential challenges, such as differentiating between co-migrating variants or handling results that fall outside of quality control limits?
  • How do you feel about embarking on this training activity, and how might these feelings influence your focus during the preparation phase?

In action

What are you doing?

  • As you begin the analysis of the HPLC plot or gel electrophoresis bands, what specific features are you focusing on first, and why have you prioritised them?
  • What decisions are you making regarding the identification of specific peaks or bands, and how are you determining their clinical significance for the case?
  • Which aspects of interpreting these electrophoretic patterns feel intuitive to you, and which parts—such as identifying rare variants or quantifying minor fractions—require more conscious effort?
  • How are you approaching the selection of these specific techniques for the clinical presentation you are investigating?

How are you progressing with the activity?

  • How effective is your current analytical approach in allowing you to interpret results for red cell, white cell, or haemostatic disorders?
  • What challenges or ambiguities are you facing as the interpretation unfolds (e.g., overlapping peaks on HPLC or faint bands on a gel)?
  • How does the data you are currently interpreting connect to your existing knowledge of haematological malignancies and transfusion serology?
  • In what ways are you applying the principles of internal quality control (IQC) and external quality assessment (EQA) to verify that the assay performance is robust before you finalise your conclusions?
  • What are you learning about the practical limitations of HPLC and gel electrophoresis as you engage with these specific results?

How are you adapting to the situation?

  • Are there alternative diagnostic techniques you should consider selecting to follow up on the findings you are currently interpreting?
  • How are you adapting your communication style in the moment to ensure your interpretation will be clear and actionable for a healthcare professional colleague?
  • What support or reference material (such as a library of variants or SOPs) do you find yourself needing to consult to resolve uncertainties in the data?
  • Are you confident that your interpretation remains within your current scope of practice and the established laboratory guidelines?

On action

What did you notice?

  • What were the key steps you took to analyse the visual data from both HPLC chromatograms and gel electrophoresis bands?
  • What specific parameters or diagnostic markers did you notice and focus on while interpreting results for cases such as red cell disorders or haematological malignancies?
  • How did you evaluate the internal quality control (IQC) and external quality assessment (EQA) data to conclude whether the assay performance was acceptable before interpreting the patient results?
  • What did you notice about the way you communicated your findings to colleagues? Were you able to present the complex data clearly and effectively?
  • Were there any unexpected challenges during the interpretation process, such as ambiguous banding or overlapping peaks, and how did you identify them?

What did you learn from the activity?

  • What new knowledge did you develop regarding the interpretation of laboratory investigations for complex cases, including haemostatic, platelet, and white cell disorders?
  • How has this experience improved your ability to select the most appropriate technique (HPLC vs. gel electrophoresis) based on the clinical presentation provided?
  • What did you learn about the practical limitations of these electrophoresis techniques, and how might these limitations lead to a need for reflex testing?
  • In what ways did your reflection-in-action (the decisions you made during the analysis) influence the final differential diagnosis you generated?
  • How does this specific experience in analysis and interpretation relate to the requirements for your post-programme professional practice as a Clinical Scientist?

What will you take from the experience moving forward?

  • What areas for continued development have you identified in your ability to correlate electrophoretic data with clinical history or to communicate those results to a multidisciplinary team?
  • How can you apply the learning from this activity to your routine laboratory practice, particularly when dealing with rare or inherited disorders of haemoglobin?
  • What specific ‘next steps’ will you now take, such as studying a wider library of variants or observing more professional discussions, to support the assimilation of what you have learned?
  • What support or resources, such as specialist clinical guidelines or mentoring from senior staff, might you need to further develop your expertise in diagnostic interpretation?

Beyond action

Have you revisited the experiences?

  • How has your understanding of the analysis and interpretation of HPLC and gel electrophoresis results evolved since you first engaged with this activity, particularly as you have encountered a wider variety of clinical scenarios?
  • When comparing your initial reflections on this task with other activities involving protein separation or complex data analysis, what specific behaviours or interpretive practices have you now successfully assimilated into your routine laboratory practice?
  • How has professional storytelling or discussing complex electrophoretic patterns with peers and senior colleagues changed your perspective on the diagnostic challenges or the limitations of these techniques?
  • As you revisit your reflections for this module, what key learning points regarding the interpretation of red cell or haemostatic disorders have you identified, and how effectively have you acted upon them?

How have these experiences impacted upon your current practice?

  • In what ways has your proficiency in interpreting electrophoresis results supported your ability to understand and contribute to subsequent investigations or multidisciplinary case studies?
  • How have you applied your knowledge of internal quality control (IQC) and external quality assessment (EQA) to current cases to ensure your conclusions about assay performance are robust before reporting?
  • How has this experience influenced your current approach to selecting the most appropriate technique when faced with a new clinical presentation in haematology or transfusion science?
  • How has your learning from this activity directly supported your preparation for observed assessments, such as Case-Based Discussions (CBDs) or Direct Observations of Practical Skills (DOPS) related to interpreting HPLC plots?
  • Can you identify instances in your current practice where your communication skills have improved when presenting electrophoresis findings to healthcare professional colleagues?

How might these experiences contribute towards your future practice?

  • Which transferable skills developed through this activity—such as analytical thinking, attention to detail, and the correlation of laboratory data with clinical history—will be most valuable in your future role as a Clinical Scientist?
  • How will your ability to identify and describe the limitations of electrophoresis techniques help you provide better diagnostic advice and ensure patient safety in more complex future investigations?
  • What clear actions have you identified for the continued development of your interpretive skills, such as mastering genotype-phenotype correlations or rare haemoglobin variant identification?
  • How will the building blocks of learning from this activity help you navigate the interpretive and analytical responsibilities of post-programme professional practice?

Relevant learning outcomes

# Outcome
# 1 Outcome

Select techniques for the investigation of clinical presentations in haematology, haemostasis and transfusion science and medicine.

# 3 Outcome

Interpret the results of the laboratory investigations for cases including red and white cell disorders and haemostatic and platelet disorders, haematological malignancy and transfusion serology.

# 4 Outcome

Describe the limitations of techniques applied in the investigation of clinical presentations in haematology, haemostasis and transfusion science.

# 5 Outcome

Apply the principles of internal quality control and external quality assessment and draw conclusions about assay performance.

# 6 Outcome

Demonstrate appropriate communication skills to present the results of investigations and cases clearly to healthcare professional colleagues.